Veridan Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Veridan Wealth's LLY Position: Q2 2026 in Review
Veridan Wealth increased its Eli Lilly (LLY) stake by 5.7% in Q2 2026, buying an estimated $16.3K and bringing the position to 299 shares worth $358K. The position accounts for 0.12% of the portfolio, ranked #68.
Veridan Wealth first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Veridan Wealth held 299 shares of Eli Lilly worth $358K as of Q2 2026.
- Veridan Wealth bought 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
- Eli Lilly made up 0.12% of Veridan Wealth's portfolio in Q2 2026, its #68 holding.
- Veridan Wealth first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
- 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Veridan Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.